ABOS icon

Acumen Pharmaceuticals

80 hedge funds and large institutions have $176M invested in Acumen Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

63% less call options, than puts

Call options by funds: $1.54M | Put options by funds: $4.13M

Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.54M
Puts
$4.13M
Net Calls
Net Calls Change

Top Buyers

1 +$8.46M
2 +$4.59M
3 +$4.45M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$836K
5
Goldman Sachs
Goldman Sachs
New York
+$823K

Top Sellers

1 -$948K
2 -$707K
3 -$530K
4
Citadel Advisors
Citadel Advisors
Florida
-$436K
5
SSA
Schonfeld Strategic Advisors
New York
-$417K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$679K
27
$603K
28
$601K
29
$548K
30
$459K
31
$455K
32
$425K
33
$385K
34
$363K
35
$331K
36
$326K
37
$311K
38
$291K
39
$259K
40
$253K
41
$250K
42
$243K
43
$243K
44
$230K
45
$228K
46
$209K
47
$197K
48
$191K
49
$151K
50
$150K